Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Vitamin K Antagonist, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Vitamin K Antagonist, Aspirin, and Clopidogrel

Fig. 9.1 Coronary angiography of the left coronary artery (AP view cranial) showing high-grade stenosis of the left anterior descending (LAD). AP antero-posterior Table 9.1 CHA2DS2-VASc score and associated risk…

read more

Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

  Condition Points Total score Stroke risk/year (%) C Congestive heart failure (or left ventricular ejection fraction ≤ 35%) 1 0 0 H Hypertension: blood pressure consistently above 140/90 mmHg…

read more

New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention

Jul 1, 2017 by in CARDIOLOGY Comments Off on New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt-, or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus, paclitaxel eluting  New generation (a) Durable polymer: zotarolimus, everolimus eluting (b) Biodegradable…

read more

Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy of Non-vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy of Non-vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with Vitamin K antagonist, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with Vitamin K antagonist, Aspirin, and Clopidogrel

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt- or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus- and paclitaxel-eluting  New generation (a) Durable polymer: zotarolimus- and everolimus-eluting (b) Biodegradable…

read more

Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt- or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus, paclitaxel eluting New generation (a) Durable polymer: zotarolimus, everolimus eluting (b) Biodegradable…

read more

Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more
Get Clinical Tree app for offline access